baber/WOPTO huggingface dataset:
Patent AU-2019340624-A1 (AU)
Title: Steel material and method of producing same
Inventor: TERAZAWA YUSUKE
IPC: C22C38/00
Filed: 2019-09-04
Abstract: Provided are a steel material and a production method for the steel material. This steel material has a component composition containing, in mass%, 0.10-2.50% of C, 8.0-45.0% of Mn, 0.300% or less of P, 0.1000% or less of S, 0.10-5.00% of Ti, 0.001-5.000% of Al, 0.5000% or less of N, 0.1000% or less of O, and C, Ti, and Mn in amounts that satisfy 25([C] - 12.01[Ti]/47.87) + [Mn] ≥ 25 (where [C], [Ti], and [Mn] represent the contained amounts (mass%) of the respective elements), the balance being Fe and incidental impurities, and has a structure containing, in area percent, 90% or more of an austenitic phase, and 0.2% or more of Ti carbide. Such a structure is obtained by heating the steel material having the component composition at a temperature of 950°C or higher, and cooling the steel material to a temperature range of 900-500°C at a cooling rate of more than 1°C/s. As a result, the steel material acquires excellent abrasion resistance. Note that by adjusting the hardness of the austenitic phase to 200 HV or more, impact abrasion resistance is significantly improved.
Patent AU-2019341728-A1 (AU)
Title: Device and system for docking an aerial vehicle
Inventor: BEN-DAVID DORON
IPC: B64D5/00
Filed: 2019-09-16
Abstract: The subject matter discloses a system for securing an aerial vehicle to a lower portion of a docking station, comprising: a docking station, comprising a top section located in an upper portion of the docking station, said top section comprises an interface configured to hang the docking station above the ground and a bottom section located in a lower portion of the docking station, said docking station comprises a latching mechanism located on said bottom section, configured to secure said aerial vehicle to said docking station. The system also comprises the aerial vehicle, comprising a docking member, said docking member is configured to dock the aerial vehicle into the docking station and to release the aerial from the latching mechanism of the docking station and a processing module configured to control the operation of the docking member.
Patent AU-2019349142-A1 (AU)
Title: Technique for controlling molecular weight of PHA copolymer produced by halobacterium
Inventor: INO Kotaro
IPC: C08G63/78
Filed: 2019-09-24
Abstract: The purpose of the present invention is to provide a PHA, in particular PHBV, having a molecular weight exceeding 3,610,000 and/or a method for producing such a PHA while controlling the molecular weight thereof. Provided is a copolymer having a weight-average molecular weight exceeding 3,610,000 wherein 3-hydroxybutanoic acid and 3-hydroxyvaleric acid are copolymerized at random.
Patent AU-2019373072-A1 (AU)
Title: Production of hydroxyethylpiperazine
Inventor: GOODMAN AMANDA M
IPC: C07D295/088
Filed: 2019-10-23
Abstract: Embodiments relate to a continuous process for the production of hydroxyethylpiperazine that includes feeding neat piperazine, recycled piperazine, and ethylene oxide to a reactor to form crude hydroxyethylpiperazine, in which the reactor is a continuous stirred tank reactor or a plug flow reactor. The process further includes continuously feeding the crude hydroxyethylpiperazine from the reactor to a distillation system that includes at least one distillation column, the distillation system produces at least a recycled piperazine stream and a hydroxyethylpiperazine stream, the recycled piperazine stream includes the recycled piperazine that is fed to the reactor to form the crude hydroxyethylpiperazine, and the hydroxyethylpiperazine stream includes at least 60 wt% of hydroxyethylpiperazine based on a total weight of the hydroxyethylpiperazine stream.
Patent AU-2019394744-A1 (AU)
Title: Topical treatment of immune checkpoint inhibitor induced diarrhoea, colitis or enterocolitis using antibodies and fragments thereof
Inventor: FURRER ESTHER MARIA
IPC: C07K16/24
Filed: 2019-12-06
Abstract: The present invention relates to the therapeutic topical use of compositions containing antibody molecules or functional fragments or derivatives specific to tumour necrosis factor alpha (TNFα), for treating or preventing immune checkpoint (ICP) inhibitor-induced adverse events.
Patent AU-2019415414-A1 (AU)
Title: Precise truck parking method, device, and system in quayside container crane area
Inventor: LI YIMING
IPC: G08G1/00
Filed: 2019-03-06
Abstract: A precise truck parking method, device, and system in a quayside container crane area. The method comprises: a vehicle controller sends a parking request of a truck (K007) to be parked (S100); a main controller (M) receives the parking request, and obtains real-time point cloud data obtained by Lidar (Lidar 1-Lidar 6) by scanning lanes (E1-E6) across which a quayside container crane stretches (S200); the main controller (M) clusters the obtained real-time point cloud data to obtain a point cloud collection of said truck (K007) (S300); the main controller (M) performs calculation on the basis of the point cloud collection of said truck (K007) and a vehicle point cloud model by an ICP algorithm to obtain the real-time distance from said truck (K007) to a target parking space (25) (S400); the vehicle controller controls said truck (K007) to stop at the target parking space (25) according to the real-time distance from said truck (K007) to the target parking space (25) (S500). The beneficial effects are that: the truck (K007) is controlled to precisely stop at the target parking space (25) in one step according to the real-time distance, and the whole parking process is completed automatically without manual direction; thus, centimeter-level accuracy and low implementation costs are achieved.
Patent AU-2020200128-A1 (AU)
Title: Non-invasive determination of methylome of fetus or tumor from plasma
Inventor: CHAN KWAN CHEE
IPC: C12Q1/68
Filed: 2020-01-08
Abstract: Systems, methods, and apparatuses can determine and use methylation profiles of various tissues and samples. Examples are provided. A methylation profile can be deduced for fetal/tumor tissue based on a comparison of plasma methylation (or other sample with cell free DNA) to a methylation profile of the mother/patient. A methylation profile can be determined for fetal/tumor tissue using tissue-specific alleles to identify DNA from the fetus/tumor when the sample has a mixture of DNA. A methylation profile can be used to determine copy number variations in genome of a fetus/tumor. Methylation markers for a fetus have been identified via various techniques. The methylation profile can be determined by determining a size parameter of a size distribution of DNA fragments, where reference values for the size parameter can be used to determine methylation levels. Additionally, a methylation level can be used to determine a level of cancer. 12010060_1 (GHMatters) P94865.AU.2 P- 0o (N cc ucu (1 , 1 cz to N N c t en (00 10( 2~~~c'c 1.0cc - c 0 cc (0 c n(c 0- 0, 'm( W - c ~ (~ m1 (1- a, (N - occrN ~~~~ OO 0(( WW c ( W ~~~M OD-t ~ crc (0 c4wcA 2c 0 C), r(0( C(0 t-0C - cc (W 00 (A cc4 '0n(0(0(0 cN ~W0(~ CM(0 (0 LN 'D L' LU cc 0 r41 ,( (-4 a) (1 ( Q . +(40' ?2D uj uj (cIfOmm IN~ IX No -nC o r Da cc cc c4 2o cc~C - (12 - ( 1Dc ( (Z: co 'o WP mm r~ mc cc ~,.0C to , a; c t- - (6 -c cc occc 0 r- (0N I - N In C(N (1 to, _ A W0( W- (N 10- cc CD -Nr4 C mN (N w0 (1'. N10CN coc c0i w0 (100 I, P,- C co 0. 0 In U4 (314 cl co ( 00 'tC 0) Lo w CNo OD0 0 , 'D CQ<, o 02 a, 0)4 j '2 22oU (3 00000 3 3 3C UU o3t 3 3 1 00.... 0 0 (N .l)D ~ ) Z ~ Z U U U U C')) (0 a)N Tn 0 r- (C) CO (0 C,) c ' 0 IT) CD) U) ~U) 0')(0 C 00 CO (Y (1)~' U ~ ~ ~ ' C ~ ~ ~ ~ c M*0 )N.- o T .CD "; (0 0 -r C') CO4 (T) 060 - 6 c 0o 00~ COU 0f 0 0 :00)g(D N vr co D'Cc'4 co C Coi r- D O co C)) C-) toC V0 q; (1 I . to M~g tr E; N. M o N.-'j S )( T - C'o (0 C(iC') 6 U)(0 & (ID CO co(1 t ( (, NUID)DC LO 0) LO a) C C, coQ to) CO U a CO N. m to W 0 _ 0 0o -0 a nC) f- D C 2I 00 . COC 04 ai -MU) T"006a o) co~ 0 Uo co4 O'4 m- l C-4 (D ') co) a) 0 U') to) o(' C>N mV -x U) () C'IT) C> a)C')l 0("N oUmom e) co O (0 00 D)l oc n ' '4. 00 0 'S 0 aO~ ) ) o M 6' ai 0 , -:U) C ~ a -C, C-4 m6 (f (D 6C; (0 6- o (ic I- m m' too 'n to v *0 U ~ N (::) U) 0O~ C4. (0C) -) C~ "O Ul a)-ja o c )A - 0 N; o 1 0 TrU o (0 Ul a)(_ oC CO r-t fl C C 4 -0 00 oU'. oo 0 W0r O(D (D E c~ ~ 222 2 U2)0 cc) m. 0o to (1 U) a) aio ~ o o 00000 t Olt~ d
Patent AU-2020200408-A1 (AU)
Title: Methods and pharmaceutical composition for the treatment and the prevention of cardiomyopathy due to energy failure
Inventor: PUCCIO HELENE MONIQUE
IPC: A61K48/00
Filed: 2020-01-21
Abstract: - '41 OF THE INVENTION METHODS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT 5 AND THE PREVENTION OF CARDIOMYOPATHY DUE TO ENERGY FAILURE The present invention relates a method for preventing or treating cardiomyopathy due to energy failure in a subject in need thereof, comprising administering to said subject a therapeutically effective amount of a vector which comprises a nucleic acid sequence of a 0 gene that can restore energy failure. More particularly, the invention relates to a method for preventing or treating a cardiomyopathy associated with Friedreich ataxia in a subject in need thereof, comprising administering to said subject a therapeutically effective amount of a vector which comprises a frataxin (FXN) encoding nucleic acid.
Patent AU-2020202692-A1 (AU)
Title: Triterpene saponins, methods of synthesis, and uses thereof
Inventor: RAGUPATHI GOVIND
IPC: A61P37/04
Filed: 2020-04-22
Abstract: [003611 The present invention relates to triterpene glycoside saponin-derived 
adjuvants, syntheses thereof, intermediates thereto, and uses thereof. QS-7 is a potent 
immune-adjuvant that is significantly less toxic than QS-21, a related saponin that is currently 
the favoured adjuvant in anticancer and antiviral vaccines. Tedious isolation and purification 
protocols have hindered the clinical development of QS-7. A novel semi-synthetic method is 
provided wherein a hydrolyzed prosapogenin mixture is used to synthesize QS-7, QS-21, and 
related analogs, greatly facilitating access to QS-7 and QS-21 analogs for preclinical and 
clinical evaluation.
Patent AU-2020210847-A1 (AU)
Title: Ballistic-resistant article based on films provided with matrix
Inventor: CALIS RUBEN
IPC: B32B27/40
Filed: 2020-01-24
Abstract: The present invention pertains to a process for the manufacture of a ballistic resistant article comprising the steps of a) stacking a stretchable lamina of ultra-high molecular weight polyethylene (UHMWPE) and a stretchable continuous film of a polymer as organic matrix material to form a lamina-film stack, the continuous film of a polymer as organic matrix material not being an UHMWPE film, b) elongating the lamina-film stack formed in step a) at a temperature below the melting point of the stretchable UHMWPE lamina, to an elongation ratio of at least 2, thereby providing a UHMWPE film with an organic matrix material in which the UHMWPE film is co-stretched with the film of polymer as organic matrix material, c) aligning a plurality of films provided according to step b) to form a layer of films, d) stacking at least two layers of films formed according to step c) to form a sheet, e) stacking a plurality of sheets formed according to step d) to form a stack of sheets, and consolidating the sheets prior to and/or after stacking according to step e) by applying pressure and optionally heat. The invention also pertains to a ballistic-resistant article that can be obtained by the claimed method.
Patent AU-2020213121-A1 (AU)
Title: Dosage and administration of anti-C5 antibodies for treatment of atypical hemolytic uremic syndrome (aHUS)
Inventor: PAYTON LORI
IPC: C07K16/18
Filed: 2020-01-24
Abstract: Provided are methods for clinical treatment of Atypical Hemolytic Uremic Syndrome (aHUS) using an anti-C5 antibody, or antigen binding fragment thereof.
Patent AU-2020217620-A1 (AU)
Title: Compounds useful for the treatment and/or care of the skin, hair, nails and/or mucous membranes
Inventor: VALERIO MAURICIO
IPC: A61K9/107
Filed: 2020-02-10
Abstract: The invention relates to a compound of formula (I) R
Patent AU-2020222382-A1 (AU)
Title: System for accessing biological samples in a cryogenic Dewar vessel
Inventor: GUSTAVO SLOBINSKY DEMIAN
IPC: F25D3/10
Filed: 2020-02-17
Abstract: A cryogenic device for storing biological material containers comprises: a sealed cryogenic Dewar vessel; (b) a matrix of receptacles disposed in an inner space of the cryogenic Dewar vessel and configured for receiving and storing biological material containers; (c) means for loading and retrieving the biological material containers. The loading/retrieving means comprises a telescopic cane manipulator configured for loading and retrieving the biological material containers within the matrix. The receptacles are carried by a carousel member rotatable around an axis thereof. The receptacles are arranged into a number of groups distributed over the carousel member. Each group of the receptacles has a central point positioned at distance R from the rotation axis of the carousel member. a center of each receptacle within the group is positioned around a central point thereof at distance R
Patent AU-2020231505-A1 (AU)
Title: Sequential intravitreal administration of AAV gene therapy to contralateral eyes
Inventor: CEPEDA DIANA
IPC: C07K16/22
Filed: 2020-03-04
Abstract: Provided are methods of treating an ocular disease or disorder in a subject, comprising: administering a unit dose of a pharmaceutical composition to a first eye the subject via intravitreal (IVT) injection at a first time point, and administering a second unit dose of the pharmaceutical composition to a contralateral eye of the subject via IVT injection at a second time point.
Patent AU-2020271043-A1 (AU)
Title: Humic and fulvic black water based beverage for human consumption
Inventor: WILKIE LOUISE
IPC: C12G3/055
Filed: 2020-04-06
Abstract: The embodiments disclose a method including bottling alcoholic beverages with selected ingredients including alcohol neutral spirits, alcohol and whisky, beer, wine, ingredients to add flavors and nutritional additive ingredients to benefit the health of an alcoholic beverage drinker, wherein a selection of alcohols includes vodka, tequila, gin, rum, brandy and other alcoholic spirits, wherein a selection of ingredients to add flavors includes flavorings including fruit flavorings, an artificial sweetener, and natural sweetener, wherein a selection of nutritional additive ingredients includes vitamins, minerals, fulvic acid, humic acid, ulmic acid and a purified and sanitized black water with humic acid and fulvic acid molecules in a mixed solution, and wherein bottling includes a bottling electronic monitoring, at least one control network, at least one bottling quality control process and a bottling labeling and packaging process and devices.
Patent AU-2020286214-A1 (AU)
Title: Persona for opaque travel item selection
Inventor: KNIGHT MATTHEW JAMES
IPC: G06F7/00
Filed: 2020-12-08
Abstract: OF THE DISCLOSURE 
A network-based service may be provided for facilitating queries for a number of 
items, such as travel services. A user may submit a query including criteria for determining 
relevant items. The network-based service may be configured to generate opaque search 
results in response to queries, revealing sufficient detail to allow the user to confirm the 
relevance of the travel item, but insufficient detail to disclose the identity of the supplier.  
Based on the submitted query or other information, the network-based service may associate 
a persona with the user, such as the persona of a business or leisure traveler. The network
based service may use the persona to determine a travel item or items best suited to the user, 
by identifying the travel item attributes that correlate positively with preferences of the 
persona. The network-based service may then generate an opaque search result that reveals 
travel item attributes desired by the persona.
Patent AU-2020289716-A1 (AU)
Title: Systems and methods for transcatheter aortic valve treatment
Inventor: ROGERS ERICA J
IPC: A61M29/02
Filed: 2020-12-14
Abstract: Devices and methods are configured to allow transcarotid or subclavian access via 
the common carotid artery to the native aortic valve, and implantation of a prosthetic 
aortic valve into the heart. The devices and methods also provide means for embolic 
protection during such an endovascular aortic valve implantation procedure.
Patent AU-2020295167-A1 (AU)
Title: Novel carbonate compound having pyrrolopyrimidine skeleton or pharmaceutically acceptable salt thereof
Inventor: MIYAKOSHI HITOSHI
IPC: C07H19/14
Filed: 2020-06-17
Abstract: [Problem] To provide: a novel carbonate compound of nucleotides which has a pyrrolopyrimidine skeleton and exhibits an excellent antitumor effect, or a pharmaceutically acceptable salt thereof; and a method for preventing and/or treating tumor by being used in combination with an alkylating agent and/or radiotherapy. [Solution] According to an aspect of the present invention, provided are: a compound represented by general formula (1) or a pharmaceutically acceptable salt; and a method for preventing and/or treating tumor by being used in combination with an alkylating agent and/or radiotherapy.
Patent AU-2020329194-A1 (AU)
Title: Improved methods for making organoid compositions
Inventor: MAYHEW CHRISTOPHER NORMAN
IPC: C12N5/00
Filed: 2020-08-11
Abstract: Disclosed herein are organoids, or compositions thereof, produced through a process of aggregating gut endoderm monolayer and culturing the resultant gut endoderm aggregate. Examples of these aggregated organoids include but are not limited to aggregated liver organoids, aggregated gastric organoids, aggregated intestinal organoids, and aggregated colonic organoids.
Patent AU-2020371898-A1 (AU)
Title: Playground apparatus
Inventor: GRØNFELDT PETER CHRISTIAN LØVFOLD
IPC: A63B9/00
Filed: 2020-10-19
Abstract: A playground apparatus having a first platform assembly, a second platform assembly, and a pole structure is disclosed. The first platform assembly includes a first platform structure disposed at a distance from the surface. The second platform assembly is disposed spaced apart from the first platform assembly. The second platform assembly includes a second platform structure disposed at a distance from the surface. Further, the pole structure is disposed between the first platform assembly and the second platform assembly, and includes a lever portion having at least one support structure for supporting one or more child. The lever portion is adapted to be pivoted between a first position and a second position. In the first position, the support structure is disposed proximate to the first platform structure, and in the second position, the support structure is disposed proximate to the second platform structure. Furthermore, a height of the at least one support structure from the surface when in the first or second position may be substantially equal to a height of the first platform structure and/or a height of the second platform structure from the surface. In this way, the apparatus facilitates an easy movement of a child between the support structure and the platform assemblies
Patent AU-2020386639-A1 (AU)
Title: Caspase 6 inhibitors and uses thereof
Inventor: RENSLO ADAM R
IPC: C07C13/11
Filed: 2020-11-20
Abstract: Disclosed herein, inter alia, are compounds and methods for inhibiting Caspase 6 and the treatment of diseases, pharmaceutical composition including a compound as described herein and a pharmaceutically acceptable excipient and methods of inhibiting human Caspase 6 protein activity, the method including: contacting the human Caspase 6 protein with a compound as described herein.
Patent AU-2020401103-A1 (AU)
Title: Process for the synthesis of N-substituted lactams and amides
Inventor: ZHANG XIAWEI
IPC: C07D207/12
Filed: 2020-12-08
Abstract: A process for the synthesis of
Patent AU-2020431679-A1 (AU)
Title: Piggyback vehicle and vehicle body thereof
Inventor: LI HUA
IPC: B61D3/18
Filed: 2020-07-30
Abstract: Disclosed are a piggyback vehicle and a vehicle body thereof. The vehicle body comprises a body part (1) and a supporting part (4), wherein a connecting structure is arranged at each of two longitudinal ends of the supporting part (4), and each connecting structure comprises an upper hook (421) and a lower circular shaft (412c) extending in the transverse direction; and the body part (1) is provided with an end connecting mechanism (22), the end connecting mechanism (22) comprises an end connecting hook (221) and an end longitudinal supporting member (222), the end connecting hook (221) forms an upward hook opening, and in an assembled state, the lower circular shaft (412c) can be hung on the hook opening of the end connecting hook (221), and the upper hook (421) can be clamped onto the end longitudinal supporting member (222). By using such a structure, two connecting points may exist between the two longitudinal ends of the supporting part (4) and the body part (1), and the supporting part (4) and the body part (1) are reliably connected; and during separation, by means of lifting the body part (1), the body part (1) and the supporting part (4) can rotate relative to one another by taking the central axis of the lower circular shaft (412c) as a rotation central line, such that the joint between the upper hook (421) and the end longitudinal supporting member (222) is forced to become loosened, and the supporting part (4) can be conveniently separated from the body part (1).
Patent WO-2022011437-A1 (WO)
Title: A storage vessel for a food processing device
Inventor: MOORE SIMON PETER
IPC: A47J43/07
Filed: 2021-07-19
Abstract: A storage structure 400 for a food processing device 10 with a bowl 16 for processing food using different accessories 82-88, that has a base unit 402 configured to fit within the bowl 16, and engagement formations 460, 474 to retain a plurality of the accessories 82-88 on the base unit 402 for individual removal from the base unit 402, and replacement into the base unit 402, without first removing or replacing another of the accessories 82-88.
Patent WO-2022115904-A1 (WO)
Inventor: MATHERS NORMAN IAN
IPC: F04C2/34
Filed: 2021-11-30
Abstract: Systems and apparatuses are disclosed that include a plurality of hydraulic vaned devices arranged in-line with one another such as along a drive line of a vehicle. Various system operation modes achieved by such devices in the in-line arrangement are also disclosed.
Patent AU-2021201600-A1 (AU)
Title: Holding tool
Inventor: REYNERTSON JOHN
IPC: B25B23/14
Filed: 2021-03-12
Abstract: of the Disclosure 
A holding tool for use in holding a first portion of an item, such as a hydraulic coupling, in a static 
position, while a torque application tool applies torque and rotates a second portion of the item. The holding 
tool helps reduce twisting of the first portion relative to the second portion when torque is applied. The 
holding tool also communicates with a controller when the tool is in use. For example, the tool 
communicates with the controller in response to a user applying a force to the tool in a direction of the first 
portion the tool is engaged with. That force releases pressure on a switch that activates a communication 
signal for communication to the controller. This allows the controller to monitor whether the holding tool 
was used in conjunction with a torque wrench to tighten the coupling; thereby providing an error reducing 
function.  
17474862_1 (GHMatters) P107411.AU.2